Neuroendocrine Tumor Registry
IRB# 199911057
Participate in registry; allow long term followup; donate blood, tissue for research, including genetics
- Thomas O'Dorisio, MD
Phase I 131I-MIBG + 177Lu-DOTATATE
IRB# 202005556
Clinical Trails.gov# NCT04614766
Dual target, dual radionuclide; dosimetry-guided therapy with AZEDRA® and Lutathera® in patients with neuroendocrine tumor or pheochromocytoma or paraganglioma
- David L. Bushnell, MD
- Kellie Bodeker, PhD
Phase I Intra-arterial 90Y-DOTATOC
IRB# 201805910
Clinical Trails.gov# NCT03724409
Dose-escalation trial for treatment of patients with liver metastases
- Sandeep Laroia, MD
- Yusuf Menda, MD
68Ga-CXCR4 Biodistribution
IRB# 201707705
Biodistribution of 68Ga-Pentixafor in patients with typical or atypical lung carcinoid tumors
- Yusuf Menda, MD
- David Dick, PhD
- M. Sue O’Dorisio, MD, PhD
68Ga-CXCR4 Biodistribution
IRB# 201907794
Biodistribution of 68Ga-Pentixafor in patients with small cell lung carcinoma
- Yusuf Menda, MD
- David Dick, PhD
- M. Sue O’Dorisio, MD, PhD
Dosimetry-guided 177Lu-DOTATATE in children
IND# 201812772
Clinical Trails.gov# NCT03923257
Phase I/II trial of 177Lu-DOTATATE (Lutathera®) for children ages six months to 19 years with neuroendocrine tumor, pheochromocytoma, or paraganglioma
- M. Sue O’Dorisio, MD, PhD
- Yusuf Menda, MD
Cabozantinib Versus Placebo in Patients with Neuroendocrine Tumors After Progression on Everolimus
IRB# 201902207
Clinical Trials.gov# 03375320
Randomized, double-blinded Phase III study of Cabozantinib versus placebo in patients with advanced lung or pancreatic neuroendocrine tumors after progression on Everolimus (CABINET)
- Chandrika Chandrasekharan, MD
- Joseph Dillon, MD
177Lu-DOTATATE in Grade 2 or 3 Neuroendocrine Tumors
IRB# 202004133
Clinical Trials.gov #03972488
A phase III multi-center, randomized, open-label study to evaluate the efficacy and safety of Lutathera® in patients with Grade 2 and Grade 3 advanced gastroentero pancreatic neuroendocrine tumors
- David Bushnell, MD
- Kellie Bodeker, PhD
- Chandra Chandrasekharan, MD